Amalgamated Bank Invitae Corp Transaction History

Amalgamated Bank

$11.7 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$0.42 - $0.72 $1,008 - $1,728	-2,400 Reduced 6.51%	34,468 $22,000
Q2 2023 Aug 11, 2023	BUY	$1.05 - $1.63 $12,762 - $19,812	12,155 Added 49.18%	36,868 $41,000
Q1 2023 May 02, 2023	SELL	$1.2 - $2.73 $7,665 - $17,439	-6,388 Reduced 20.54%	24,713 $33,000
Q4 2022 Feb 10, 2023	BUY	$1.71 - $3.61 $1,826 - $3,855	1,068 Added 3.56%	31,101 $58,000
Q3 2022 Nov 09, 2022	BUY	$1.9 - $8.63 $1,489 - $6,765	784 Added 2.68%	30,033 $74,000
Q2 2022 Aug 15, 2022	BUY	$2.13 - $9.01 $6,149 - $26,011	2,887 Added 10.95%	29,249 $71,000
Q1 2022 Jun 30, 2022	SELL	$6.28 - $15.59 $12,578 - $31,226	-2,003 Reduced 7.06%	26,362 $210,000
Q4 2021 Feb 15, 2022	SELL	$14.7 - $28.67 $3,954 - $7,712	-269 Reduced 0.94%	28,365 $433,000
Q3 2021 Oct 29, 2021	SELL	$24.31 - $33.6 $48,717 - $67,334	-2,004 Reduced 6.54%	28,634 $814,000
Q2 2021 Aug 16, 2021	BUY	$26.09 - $40.4 $348,927 - $540,309	13,374 Added 77.47%	30,638 $1.03 Million
Q1 2021 May 13, 2021	SELL	$33.06 - $56.93 $25,654 - $44,177	-776 Reduced 4.3%	17,264 $660,000
Q4 2020 Feb 12, 2021	BUY	$39.09 - $57.4 $3,635 - $5,338	93 Added 0.52%	18,040 $754,000
Q3 2020 Oct 30, 2020	SELL	$28.43 - $44.67 $14,925 - $23,451	-525 Reduced 2.84%	17,947 $778,000
Q2 2020 Aug 10, 2020	BUY	$11.71 - $30.29 $33,408 - $86,417	2,853 Added 18.27%	18,472 $560,000
Q1 2020 May 13, 2020	SELL	$7.64 - $27.5 $5,386 - $19,387	-705 Reduced 4.32%	15,619 $214,000
Q4 2019 Feb 13, 2020	BUY	$15.02 - $20.57 $13,923 - $19,068	927 Added 6.02%	16,324 $263,000
Q3 2019 Nov 13, 2019	SELL	$18.85 - $27.5 $3,788 - $5,527	-201 Reduced 1.29%	15,397 $297,000
Q2 2019 Aug 14, 2019	BUY	$17.37 - $26.27 $85,008 - $128,565	4,894 Added 45.72%	15,598 $367,000
Q1 2019 May 15, 2019	BUY	$10.65 - $25.75 $113,997 - $275,628	10,704 New	10,704 $251,000

Others Institutions Holding NVTA

# of Institutions

Shares Held

2.12M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account